FRX fundamentals
An in-depth look to FENNEC PHARMACEUTICALS INC operating, investing, and financing activities
FRX free cash flow for Q4 23 is -6.59 M CAD. For 2023, FRX free cash flow was -23.14 M CAD and operating cash flow was -23.14 M CAD.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CAD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM